Different Manifestations of Postcoital Cystitis and the Role of the Pelvic Floor

Postcoital cystitis (PCC) is a form of recurrent cystitis in which episodes occur shortly after sexual intercourse. It accounts for up to 60% of all recurrent cystitis in women of childbearing age and is caused by a combination of anatomical, microbiotic, hormonal and muscular factors that interact differently from woman to woman.

Yes. PCC affects mainly young, sexually active women, with the highest prevalence between the ages of 18 and 29. The condition does not disappear with age: in menopause, 40% of women with recurrent cystitis identify sexual intercourse as a trigger. In the Dimann dataset analysed in this white paper, the PCC sub-sample includes 22,716 women out of 34,277.

50.4% of women with PCC in the sample recognise that sexual intercourse triggers their cystitis, but have never received this diagnosis. They do not know the name of their condition and, consequently, are unaware that a specific preventive strategy exists. Patients wait an average of three years from onset before a targeted approach is proposed.

PCC results from multiple concurrent factors. Bacterial ascent during intercourse is facilitated by the anatomical proximity between the urethral meatus and the vaginal opening, but also depends on the integrity of the vaginal microbiota, hormonal status, quality of sexual arousal, the ability of bacteria to persist inside urothelial cells, and the health of the pelvic floor.

Uropathogenic Escherichia coli can form intracellular bacterial communities sheltered from antibiotics and the immune system. These reservoirs can remain dormant for weeks before reactivating in response to the mechanical trauma of sexual intercourse. Repeated antibiotic use can also weaken the vaginal microbiota, reducing the primary biological barrier that protects against recurrence.

The pelvic floor is probably the most overlooked pathophysiological link in the management of PCC. Levator ani hypertonia amplifies mechanical trauma during penetration and is present in more than 60% of women with recurrent cystitis. Yet fewer than 1% of women with PCC have ever consulted a pelvic floor physiotherapist.

Cystitis inflames the bladder and sensitises the nerve fibres of the vaginal vestibule. Vestibular pain triggers a defensive contraction of the pelvic floor, which amplifies urethral trauma during subsequent intercourse, facilitating recurrence. Each episode makes the cycle harder to break without an intervention targeting the muscular mechanism, such as pelvic physiotherapy.

No. Cluster analysis on 22,716 women with PCC identified three clinically distinct subtypes: episodic PCC (46.2%), the most common and least complicated form; complicated PCC (29.7%), with strong pelvic floor involvement and severe impact on quality of life; and menopausal PCC (24.1%), defined primarily by oestrogen deficiency.

Yes. In menopause, oestrogen deficiency thins the protective lining of the bladder, reduces urethral tone and weakens the vaginal microbiota, increasing vulnerability to bacterial ascent. In this context the causal link to sexual intercourse may be less obvious, and the diagnosis of menopausal PCC is often delayed.

Yes, and not as a psychological side effect: the link is neurobiological. Anxiety activates the sympathetic nervous system, increases pelvic floor tone and reduces lubrication. In complicated PCC, stress emerges as a concrete pathophysiological factor. Moreover, 83% of women with PCC develop symptoms of depression or anxiety disorder during the course of the condition.

Yes. Women with PCC rate the condition with a median importance of 10 out of 10 in their lives. Sexual intercourse can shift from an experience of intimacy to an anticipation of pain and recurrence. The effects extend to partners: avoidance behaviours, erectile dysfunction and separations are documented in couples where a woman lives with postcoital cystitis.

The white paper proposes a subtype-differentiated approach: pelvic floor physiotherapy for those with muscle hypertonia, local hormonal support for menopausal PCC, targeted post-coital antibiotic prophylaxis for episodic PCC, and psychosexual support for those with emotional and relational involvement. There is no single PCC and there can be no single therapeutic strategy.